Kemps-Polanco Reshema
Director
Avg. Two Year Performance
No Purchase Track Record
No Sale Track Record
Holdings: 1.01K shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions